Méthanor SCA

ALMET

The current Méthanor SCA (ALMET) market capitalization is approximately €6.03M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Méthanor SCA's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:45 PM Eastern Time

In the most recently reported quarter, Méthanor SCA (ALMET) generated €1.79K in revenue, representing a -94.70% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 2:31 AM Eastern Time

In the most recently reported fiscal year, Méthanor SCA (ALMET) generated net income of €-0.71M, compared with €297.35K in the prior fiscal year, representing a -340.35% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of €800.00K. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 2:31 AM Eastern Time

As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.00x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: January 1, 2026 at 2:31 AM Eastern Time

Méthanor SCA (ALMET) is currently scheduled to report its next earnings results on April 27, 2026. Earnings dates are subject to change and may be updated by the company with limited notice. Investors typically monitor upcoming earnings releases closely, as they can result in increased volatility depending on reported results, forward guidance, and management commentary. Last updated: December 31, 2025 at 11:45 PM Eastern Time

In the most recently reported quarter, Méthanor SCA (ALMET) revenue was €1.79K. Earnings per share (EPS) for the quarter were €0.24. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 2:31 AM Eastern Time

Méthanor SCA (ALMET) does not currently pay a dividend. Over the last twelve months (LTM), the company paid €0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: January 1, 2026 at 2:31 AM Eastern Time

Analyst assessments of whether Méthanor SCA (ALMET) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: €2.50Consensus price target: €5.33Implied return: +113.20% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: January 1, 2026 at 11:30 AM Eastern Time

Based on the latest available analyst coverage, Méthanor SCA (ALMET) currently carries a Buy consensus rating. Analysts' average ALMET price target is €5.33. Relative to the current share price of €2.50, this suggests a potential price change of approximately +113.20%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 11:30 AM Eastern Time

Like other publicly traded stocks, Méthanor SCA (ALMET) shares are bought and sold on stock exchanges such as ENXTPA and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Méthanor SCA (ALMET) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add ALMET to your watchlist.

Méthanor SCA trades under the ticker symbol ALMET on the ENXTPA stock exchange. The ticker ALMET is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.